Capra Biosciences

📍 MANASSAS, United States👥 18 employees💰 Last funded Dec 2023
Biotechnology Research🌐 caprabiosciences.com
Website LinkedIn
Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Capra Biosciences?
Capra Biosciences has 2 investors on record on gritt.io.
When did Capra Biosciences last raise funding?
The most recent investment in Capra Biosciences recorded on gritt.io was in December 2023.
What industry is Capra Biosciences in?
Capra Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Capra Biosciences based?
Capra Biosciences is headquartered in MANASSAS, United States.